Eblasakimab Antibody
Eblasakimab (ASLAN004) is a humanized monoclonal antibody designed to inhibit the IL-13 receptor alpha subunit, thereby blocking signaling of IL-4 and IL-13 through the type 2 receptor. This mechanism makes it a relevant tool for investigating the pathophysiology and potential therapeutic strategies for atopic dermatitis in both in vitro and in vivo research models.
Product Specifications
Product Name Alternative
CSL334, CSL-334, ASLA N004, ASLAN004
Target
Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
7.31 mg/mL
Purity
98.18% (May vary between batches)
Molecular Weight
143.86 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
480753 100 µL
FAM45B (Protein FAM45B, Family with Sequence Similarity 45, Member A Pseudogene)
Sign In for Pricing
View Details 
TMAB-06538-01 50 μL
Anti-Glucose 6 Phosphate Dehydrogenase Polyclonal Antibody
Sign In for Pricing
View Details TMAB-06538-02 100 µL
Anti-Glucose 6 Phosphate Dehydrogenase Polyclonal Antibody
Sign In for Pricing
View Details TMAB-06538-03 200 µL
Anti-Glucose 6 Phosphate Dehydrogenase Polyclonal Antibody
Sign In for Pricing
View Details